Skip to main content
Clinical Trials/ISRCTN87551289
ISRCTN87551289
Completed
Not Applicable

Strengthening hip muscles to improve walking distance in people with Charcot-Marie-Tooth disease: a randomised single-blinded crossover trial

niversity College London Hospitals NHS Foundation Trust (UK)0 sites32 target enrollmentMay 12, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity College London Hospitals NHS Foundation Trust (UK)
Enrollment
32
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 12, 2009
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity College London Hospitals NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • People will be recruited provided all of the following criteria are satisfied:
  • 1\. Clinical diagnosis of Charcot\-Marie\-Tooth disease (CMT)
  • 2\. Aged 18 to 70 years, either sex
  • 3\. Able to walk for 50 m with or without a walking aid or orthotic devices
  • 4\. Signed informed participant consent

Exclusion Criteria

  • People will be excluded from the study if one or more of the following criteria apply:
  • 1\. Presence of other significant neurological disorders (such as multiple sclerosis, cerebrovascular diseases, movement disorders), or major comorbidities (e.g., definite cognitive impairment, psychiatric disease, heart or lung failure, orthopaedic or rheumatological disorders)
  • 2\. Limb surgery during the six months prior to screening (or planned before final assessment)
  • 3\. Severe congenital hip dysplasia associated with CMT
  • 4\. Aged over 70 or under 18 years
  • 5\. Women of child\-bearing age only if they are pregnant at the inclusion into the study or plan to become pregnant during the study (people agreeing not to become pregnant during the study must take appropriate contraceptive methods \- contraceptive pill, intrauterine device, barrier methods)

Outcomes

Primary Outcomes

Not specified

Similar Trials